INHIBITION OF SARS CORONAVIRUS INFECTION WITH CLINICALLY APPROVED ANTIVIRAL DRUGS

摘要

The invention relates to methods for treating or inhibiting SARS-CoV infection involving the administration of an interferon, particularly IFN α-n1, IFN α-n3, human leukocyte IFN α or IFN β-1b.